Mydecine Innovations Group Inc.
MYCOF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,152 | -$20,947 | -$17,242 | -$23,583 |
| Dep. & Amort. | $0 | $10 | $129 | $235 |
| Deferred Tax | $0 | $0 | $0 | $480 |
| Stock-Based Comp. | $0 | $0 | $0 | $3,100 |
| Change in WC | $212 | $5,297 | $8,211 | -$4,593 |
| Other Non-Cash | $2,903 | $11,423 | $474 | $309 |
| Operating Cash Flow | -$37 | -$4,217 | -$8,428 | -$24,052 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$35 | -$404 |
| Net Acquisitions | $0 | $0 | -$2 | $0 |
| Inv. Purchases | $0 | $0 | $0 | -$69 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $525 | $0 | $0 |
| Investing Cash Flow | $0 | $525 | -$38 | -$474 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $110 | $73 | $5,500 |
| Stock Issued | $0 | $3,608 | $6,908 | $15,333 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $2,998 |
| Financing Cash Flow | $0 | $3,718 | $6,981 | $23,831 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$37 | $27 | -$1,484 | -$695 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $38 | $11 | $1,495 | $2,191 |
| End Cash | $0 | $38 | $11 | $1,495 |
| Free Cash Flow | -$37 | -$4,217 | -$8,463 | -$24,457 |